{"id":"W2569887051","doi":"10.1007/s12325-016-0467-6","title":"Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age","year":2017,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Cilag; Takeda Oncology; Pfizer; Takeda Pharmaceuticals International; Biogen; Bristol-Myers Squibb","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Placebo; Adverse effect; Incidence (geometry); Clinical trial; Gastroenterology; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001350084,0.0002816299,0.0007816066,0.0003788166,0.000269748,0.0004489879,0.000129227,0.0003749779,0.001165379],"category_scores_gemma":[0.001973932,0.000130522,0.001061667,0.0003810921,0.0001825202,0.0002999064,0.0003036958,0.0004312836,0.0001448631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002104039,"about_ca_system_score_gemma":0.0002594742,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004082429,"about_ca_topic_score_gemma":0.000879965,"domain_scores_codex":[0.9992532,0.0003196518,0.00009554828,0.0001166646,0.0001046042,0.0001102782],"domain_scores_gemma":[0.9985743,0.0003481592,0.0007152451,0.00006385725,0.0000783709,0.000220147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06475496,0.000466365,0.9038261,0.0002051797,0.001562317,0.0001227486,0.0001070608,0.0003507439,0.002481564,0.00005291736,0.0003845877,0.02568542],"study_design_scores_gemma":[0.00173147,0.009741727,0.9854188,0.00005255836,0.0009200467,0.0002903093,0.0000724397,0.000424763,0.0005046142,0.00008550932,0.0007475798,0.00001020559],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969112,0.002414826,0.00005198927,0.00005619091,0.00001085512,0.00002534736,0.0001815407,0.000001920557,0.0003461516],"genre_scores_gemma":[0.9992249,0.0003007474,0.00007204989,0.00004987209,0.00002088927,0.00001618083,0.0002535696,5.590744e-7,0.00006127093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001350084,"threshold_uncertainty_score":0.00714004,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006579731256089791,"score_gpt":0.2727616399943329,"score_spread":0.2661819087382431,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}